Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Pediatric Hematology/Oncology
•
BRAF+
•
Langerhans Cell Histiocytosis
Do you recommend using cell-free BRAFV600E to track response to therapy in pediatric patients with langerhans cell histiocytosis?
Related Questions
How do you approach adjuvant therapy for resected Stage I Ewing sarcoma of the kidney, and what chemotherapy regimen and cycle duration do you recommend?
What is your criteria for considering oral, or IV, iron repletion in pediatric patients referred to Hematology for restless leg syndrome?
At what point should surgical intervention be considered for vestibular schwannomas or other tumors in pediatric NF2 patients?
Can lupus anticoagulant be positive despite a normal aPTT?
What experience have you had with familial clustering of polycythemia vera?
How do you counsel patients with acute intermittent porphyria when it comes to fasting for religious reasons?
What cardiac surveillance would you do for an asymptomatic male patient with a remote history of mantle field radiation for Hodgkin's lymphoma?
For mild to moderate hemophilia B, do you routinely screen for inhibitors?
What is your standard for monitoring triglyceride level during therapy for ALL, particularly in regards to receiving pegaspargase?
What is the expected timeframe for the development of radiation myelitis and therapies that have helped with neurologic symptoms?
